Identifies the overgrowth of large intestinal bacteria in the small intestine and the release of bacterial cytotoxin and evaluates a breach of intestinal barrier by cytotoxins and their entry into circulation.
Clinical Use
Identify the overgrowth of large intestinal bacteria in the small intestine and the release of bacterial cytotoxins
Evaluate a breach of intestinal barrier by bacterial cytotoxins and their entry into circulation
Assist in setting guidelines for treatment of irritable bowels/SIBO and reduce risk of igniting the autoimmune process
Recommended for Patients Who
Have irritable bowels
Exhibit symptoms of malabsorption, including weight loss, anemia or fatty stools
Have associated conditions such as fatigue, reflux, skin disorders, obesity or food intolerances